Abstract

A controversial trial from the U.K. previously reported increased mortality in patients with early, mild Parkinson's disease when they were treated

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call